Ticker Details
Abeona Therapeutics Inc. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
IPO Date:	November 9, 1984
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$310.05M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 3.65%
Avg Daily Range (30 D):	$0.13 | 2.34%
Avg Daily Range (90 D):	$0.11 | 2.22%

Institutional Daily Volume
Avg Daily Volume:	.58M
Avg Daily Volume (30 D):	1.04M
Avg Daily Volume (90 D):	1.12M

Trade Size
Avg Trade Size (Sh.):	191
Avg Trade Size (Sh.) (30 D):	121
Avg Trade Size (Sh.) (90 D):	126

Institutional Trades
Total Institutional Trades:	421
Avg Institutional Trade:	$1.43M
Avg Institutional Trade (30 D):	$.68M
Avg Institutional Trade (90 D):	$.78M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.69M
Avg Closing Trade (30 D):	$.7M
Avg Closing Trade (90 D):	$.7M
Avg Closing Volume:	52.56K

News

Dec 31, 2025 @ 12:30 PM Abeona Therapeutics® Announces New Employee Ind... Source: Na

Nov 12, 2025 @ 4:37 PM Here's Why Abeona Therapeutics Popped Higher Today... Source: Lee Samaha

Sep 2, 2025 @ 8:59 AM Trends & Growth Strategies in the $13.5 Billion Ca... Source: Researchandmarkets.Com

Aug 12, 2025 @ 2:00 PM AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 ... Source: Dea Belazi

May 14, 2025 @ 5:57 PM US FDA Orphan Drug Rare Disease Market Clinical Tr... Source: Kuick Research

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS		$-.3	$-.1
Diluted EPS		$-.3	$-.1
Revenue		$8.72M	$M
Gross Profit
Net Income / Loss		$-17.08M	$-5.16M
Operating Income / Loss		$-23.03M	$-24.02M
Cost of Revenue
Net Cash Flow		$-17.06M	$-80.65M
PE Ratio

Splits
Jul 05, 2022	1:25
Oct 24, 2014	1:50
Jun 05, 2006	1:5